Inhaled Laninamivir Octanoate as Prophylaxis for Influenza in Children
Authors:
- Koji IsobeKIKoji Isobe
- for the Laninamivir Prophylaxis Study GroupFGfor the Laninamivir Prophylaxis Study Group
Open Access
- 1 December 2016
- journal article
- research article
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 138 (6) , e20160109
Abstract
BACKGROUND: A single 20-mg dose of inhaled laninamivir octanoate is an effective treatment of influenza. However, the efficacy of laninamivir octanoate for the prevention of influenza in children <10 years of age has not yet been established. METHODS: We conducted a double-blind, multicenter, randomized, placebo-controlled study to determine whether the efficacy of a single 20-mg dose of inhaled laninamivir octanoate to prevent the development of influenza was superior to that of placebo as prophylaxis for influenza in pediatric (<10 years) household members of index cases. Eligible subjects without influenza, in contact with an influenza-infected index case living in the same household, were blindly randomly assigned in a 1:1 ratio to receive 20 mg of laninamivir octanoate or placebo. The primary end point was the proportion of subjects who developed clinical influenza during a 10-day period. RESULTS: A total of 343 subjects were randomly assigned, with 341 subjects included in the full analysis set for the primary analysis. The proportions of subjects who developed clinical influenza were 11% (18/171) in the laninamivir octanoate group and 19% (33/170) in the placebo group (P = .02). The relative risk reduction was 45.8% (95% confidence interval, 7.5% to 68.2%). The incidence of adverse events was similar in both groups. CONCLUSIONS: A single 20-mg dose of inhaled laninamivir octanoate was effective and well tolerated as prophylaxis for influenza.Keywords
This publication has 19 references indexed in Scilit:
- Characterization of a Large Cluster of Influenza A(H1N1)pdm09 Viruses Cross-Resistant to Oseltamivir and Peramivir during the 2013-2014 Influenza Season in JapanAntimicrobial Agents and Chemotherapy, 2015
- Oseltamivir-resistant influenza A(H1N1)pdm2009 strains found in Brazil are endowed with permissive mutations, which compensate the loss of fitness imposed by antiviral resistanceMemórias do Instituto Oswaldo Cruz, 2015
- Abnormal behavior during influenza in Japan during the last seven seasons: 2006–2007 to 2012–2013Journal of Infection and Chemotherapy, 2014
- Oseltamivir treatment for children showing abnormal behavior during influenza virus infectionBrain and Development, 2010
- In vitro and in vivo characterization of new swine-origin H1N1 influenza virusesNature, 2009
- CS-8958, a Prodrug of the New Neuraminidase Inhibitor R-125489, Shows Long-Acting Anti-Influenza Virus ActivityAntimicrobial Agents and Chemotherapy, 2009
- Assessment of Neuropsychiatric Adverse Events in Influenza Patients Treated with OseltamivirDrug Safety, 2008
- Influenza-Associated Hospitalizations in the United StatesJAMA, 2004
- Incidence of Outpatient Visits and Hospitalizations Related to Influenza in Infants and Young ChildrenPediatrics, 2004
- Influenza and the Rates of Hospitalization for Respiratory Disease among Infants and Young ChildrenNew England Journal of Medicine, 2000